Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 244

The DOI matches its Crossref record.

Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis

Open access
Bañares, Rafael, Moitinho, Eduardo, Matilla, Ana, García-Pagán, Juan Carlos, Lampreave, José Luis, Piera, Carlos, Abraldes, Juan G., De Diego, Alejandro, Albillos, Agustín, Bosch, Jaime·2002·Hepatology

Abstract

Short-term carvedilol administration is more powerful than propranolol in decreasing hepatic venous pressure gradient (HVPG) in cirrhotic patients, but induces arterial hypotension that may prevent its long-term use in portal hypertensive patients. This study compared the HVPG reduction and safety of long-term carvedilol and propranolol. Fifty-one cirrhotic patients were randomly assigned to receive carvedilol (n = 26) and propranolol (n = 25). Hemodynamic measurements and renal function were assessed at baseline and after 11.1 ± 4.1 weeks. Carvedilol caused a greater decrease in HVPG than popranolol (− 19 ± 2% vs. − 12 ± 2%;P< 0.001). The proportion of patients achieving an HVPG reduction ≥20% or ≤ 20 mm Hg was greater after carvedilol (54% vs. 23%;P< 0.05). Carvedilol, but not propranolol caused a significant decrease in mean arterial pressure (MAP) (- 11 ± 1% vs. - 5 ± 3%;P= 0.05) and a significant increase in plasma volume (PV) and body weight (11 ± 5% and 2 ± 1%, respectively;P< 0.05). Glomerular filtration rate (GFR) was unchanged with either drug, but the dose of diuretics was increased more frequently after carvedilol (27% vs. 8%P= 0.07). Adverse events requiring discontinuation of treatment occurred in 2 patients receiving carvedilol and in 3 receiving propranolol. In conclusion, carvedilol has a greater portal hypotensive effect than propranolol in patients with cirrhosis. However, its clinical applicability may be limited by its systemic hypotensive effects. Further trials are needed to confirm the therapeutic potential of carvedilol. (Hepatology2002;36:1367-1373).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.1840360612

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 244

Metadata

Authors
Bañares, R., Moitinho, E., Matilla, A., García-Pagán, J. C., Lampreave, J. L., Piera, C., Abraldes, J. G., De Diego, A., Albillos, A., & Bosch, J.
Venue
Hepatology
Published
2002-12
Volume
36
Issue
6
Pages
1367-1373
ISSN
0270-9139 (ISSN-L)
OpenAlex
W2095394267
Cited by
244
References
0
FWCI
3.72
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. https://app.cochat.ai/papers/10.1002/hep.1840360612
The paper
Bañares, R., Moitinho, E., Matilla, A., García-Pagán, J. C., Lampreave, J. L., Piera, C., Abraldes, J. G., De Diego, A., Albillos, A., & Bosch, J. (2002). Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology. https://doi.org/10.1002/hep.1840360612

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.